These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6352802)

  • 21. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiton of IL 2 production after human allogeneic bone marrow transplantation.
    Azogui O; Gluckman E; Fradelizi D
    J Immunol; 1983 Sep; 131(3):1205-8. PubMed ID: 6224851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct roles of IL-1 and IL-6 in human T cell activation.
    Houssiau FA; Coulie PG; Van Snick J
    J Immunol; 1989 Oct; 143(8):2520-4. PubMed ID: 2794507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
    Yamaguchi E
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM; Kumar A; Kryworuchko M; Diaz-Mitoma F
    J Immunol; 1996 Jul; 157(1):12-20. PubMed ID: 8683105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
    Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
    Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral blood.
    Moretti L; Giuliodori L; Stramigioli S; Luchetti F; Baldi A; Sparaventi G
    Haematologica; 1992; 77(6):463-9. PubMed ID: 1289183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester.
    de Vries JE; Vyth-Dreese FA; Figdor CG; Spits H; Leemans JM; Bont WS
    J Immunol; 1983 Jul; 131(1):201-6. PubMed ID: 6408170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective interleukin 2 (IL2) production by peripheral blood mononuclear cells (PBMC) of bone marrow transplant recipients is not due to accessory cell or T cell receptor defects.
    Cooley MA; McLachlan K; Atkinson K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3060-1. PubMed ID: 2650425
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro.
    Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
    Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
    Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of major trauma on the regulatory levels of interleukin-1 (IL-1) and IL-2 in human mononuclear leukocytes.
    Faist E; Schinkel C; Zimmer S; Kremer JP; Alkan S; Rordorf C; von Donnersmarck H; Schildberg FW
    Zentralbl Chir; 1993; 118(7):420-31. PubMed ID: 8372524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.
    Watson JD
    J Immunol; 1983 Jul; 131(1):293-7. PubMed ID: 6602832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis.
    Godot V; Harraga S; Deschaseaux M; Bresson-Hadni S; Gottstein B; Emilie D; Vuitton DA
    Eur Cytokine Netw; 1997 Dec; 8(4):401-8. PubMed ID: 9459621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood mononuclear cells (PBMC) from recipients of human bone marrow allografts suppress mitogen-induced proliferation of marrow donor PBMC.
    Cooley MA; Chapman G; Atkinson K; Biggs JC
    Transplant Proc; 1986 Apr; 18(2):270-2. PubMed ID: 2938313
    [No Abstract]   [Full Text] [Related]  

  • 39. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.